ASH 2021 ROUNDTABLE DISCUSSIONS: LEUKEMIA, LYMPHOMA & MULTIPLE MYELOMA

LEARNING OBJECTIVES:

  • Summarize and provide expert opinions on the most significant clinical trial data presented at ASH 2021.
  • Discuss the impact of the ASH 2021 data on Canadian clinical practice and the current standard of care.
  • Discuss controversies and key questions for future studies generated by data released at ASH 2021.

ASH 2021 ROUNDTABLE DISCUSSIONS: MULTIPLE MYELOMA

Learning Objectives: ASH 2021 ROUNDTABLE DISCUSSIONS: MULTIPLE MYELOMA LEARNING OBJECTIVES Summarize and provide expert opinions on the most significant clinical trial data presented at ASH 2021. Discuss the impact of the ASH 2021 data on Canadian clinical practice...

ASH 2021 ROUNDTABLE DISCUSSIONS: LYMPHOMA

Key Content Areas Include: ASH 2021 ROUNDTABLE DISCUSSIONS: LYMPHOMA LEARNING OBJECTIVES Summarize and provide expert opinions on the most significant clinical trial data presented at ASH 2021. Discuss the impact of the ASH 2021 data on Canadian clinical practice and...

ASH 2021 ROUNDTABLE DISCUSSIONS: LEUKEMIA

Key Content Areas Include: ASH 2021 ROUNDTABLE DISCUSSIONS: LEUKEMIA LEARNING OBJECTIVES: Summarize and provide expert opinions on the most significant clinical trial data presented at ASH 2021. Discuss the impact of the ASH 2021 data on Canadian clinical practice and...